Hospital readmissions among patients with decompensated cirrhosis
- PMID: 21931378
- PMCID: PMC3470789
- DOI: 10.1038/ajg.2011.314
Hospital readmissions among patients with decompensated cirrhosis
Abstract
Objectives: Early rehospitalizations have been well characterized in many disease states, but not among patients with cirrhosis. The aims of this study were to identify the frequency, costs, predictors, and preventable causes of hospital readmissions among patients with decompensated cirrhosis.
Methods: Rates of readmission were calculated for 402 patients discharged after one of the following complications of cirrhosis: ascites, spontaneous bacterial peritonitis, renal failure, hepatic encephalopathy, or variceal hemorrhage. Costs of readmissions were calculated using the hospital accounting system. Predictors of time to first readmission were determined using Cox regression, and predictors of hospitalization rate/person-years were determined using negative binomial regression. The independent association between readmission rate and mortality was determined using Cox regression. Admissions within 30 days of discharge were assessed by two reviewers to determine if preventable.
Results: Overall, 276 (69%) subjects had at least one nonelective readmission, with a median time to first readmission of 67 days. By 1 week after discharge, 14% of subjects had been readmitted, and 37% were readmitted within 1 month. The mean costs for readmissions within 1 week and between weeks 1 and 4 were $28,898 and $20,581, respectively. During a median follow-up of 203 days, the median number of readmissions was 2 (range 0-40), with an overall rate of 3 hospitalizations/person-years. Patients with more frequent readmissions had higher risk of subsequent mortality, despite adjustment for confounders including the Model for End-stage Liver Disease (MELD) score. Predictors of time to first readmission included MELD score, serum sodium, and number of medications on discharge; predictors of hospitalization rate included these variables as well as the number of cirrhosis complications and being on the transplant list at discharge. Among 165 readmissions within 30 days, 22% were possibly preventable.
Conclusions: Hospital readmissions among patients with decompensated cirrhosis are common, costly, moderately predictable, in some cases, possibly preventable, and independently associated with mortality. These findings support the development of disease management interventions to prevent rehospitalization.
Conflict of interest statement
Conflicts of interest: none of the authors has any conflict of interest for this study.
Figures
Comment in
-
Hospital Readmissions in Decompensated Cirrhosis.Am J Gastroenterol. 2015 Jun;110(6):940. doi: 10.1038/ajg.2015.142. Am J Gastroenterol. 2015. PMID: 26052778 No abstract available.
Similar articles
-
Nationwide estimates and risk factors of hospital readmission in patients with cirrhosis in the United States.Liver Int. 2019 May;39(5):878-884. doi: 10.1111/liv.14054. Epub 2019 Feb 25. Liver Int. 2019. PMID: 30688401
-
Risk Factors for 30-Day Readmissions of Individuals with Decompensated Cirrhosis.South Med J. 2015 Nov;108(11):682-7. doi: 10.14423/SMJ.0000000000000371. South Med J. 2015. PMID: 26539950
-
Burden of decompensated cirrhosis and ascites on hospital services in a tertiary care facility: time for change?Intern Med J. 2014 Sep;44(9):865-72. doi: 10.1111/imj.12491. Intern Med J. 2014. PMID: 24893971
-
Strategies to Reduce Hospital Readmissions.Semin Liver Dis. 2016 May;36(2):161-6. doi: 10.1055/s-0036-1583196. Epub 2016 May 12. Semin Liver Dis. 2016. PMID: 27172358 Review.
-
The Burden of Rehospitalization for Patients With Liver Cirrhosis.Hosp Pract (1995). 2016;44(1):60-9. doi: 10.1080/21548331.2016.1142828. Epub 2016 Feb 3. Hosp Pract (1995). 2016. PMID: 26782133 Review.
Cited by
-
Privacy-preserving large language models for structured medical information retrieval.NPJ Digit Med. 2024 Sep 20;7(1):257. doi: 10.1038/s41746-024-01233-2. NPJ Digit Med. 2024. PMID: 39304709 Free PMC article.
-
Trends in the burden of hospitalised patients with cirrhosis in Switzerland: a cross-sectional study of cirrhosis-related hospitalisations between 1998 and 2020.BMJ Open. 2024 Aug 24;14(8):e081822. doi: 10.1136/bmjopen-2023-081822. BMJ Open. 2024. PMID: 39181561 Free PMC article.
-
Feasibility of an Interprofessional Inpatient Educational Intervention for Patients With Decompensated Cirrhosis.Gastro Hep Adv. 2024 Mar 22;3(5):615-617. doi: 10.1016/j.gastha.2024.03.011. eCollection 2024. Gastro Hep Adv. 2024. PMID: 39165423 Free PMC article. Review. No abstract available.
-
Inpatient Outcomes of Cirrhosis-related Cachexia in the United States.Gastro Hep Adv. 2023 Dec 7;3(3):410-416. doi: 10.1016/j.gastha.2023.11.017. eCollection 2024. Gastro Hep Adv. 2023. PMID: 39131152 Free PMC article.
-
Discharge Outcomes of Hospitalized Patients with New Onset Decompensated Cirrhosis.Dig Dis Sci. 2024 Sep;69(9):3220-3225. doi: 10.1007/s10620-024-08574-8. Epub 2024 Jul 31. Dig Dis Sci. 2024. PMID: 39085484 Free PMC article.
References
-
- Kim WR, Brown RS, Jr, Terrault NA, et al. Burden of liver disease in the United States: summary of a workshop. Hepatology. 2002;36:227–242. - PubMed
-
- Talwalkar JA. Prophylaxis with beta blockers as a performance measure of quality health care in cirrhosis. Gastroenterology. 2006;130:1005–1007. - PubMed
-
- Nguyen GC, Segev DL, Thuluvath PJ. Nationwide increase in hospitalizations and hepatitis C among inpatients with cirrhosis and sequelae of portal hypertension. Clin Gastroenterol Hepatol. 2007;5:1092–1099. - PubMed
-
- Institute of Medicine (U.S.) Crossing the quality chasm : a new health system for the 21st century. Washington, D.C.: National Academy Press; 2001. Committee on Quality of Health Care in America. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
